UTI Healthcare Fund - Regular Plan - Growth Option
Invest Now
Fund Manager: V Srivatsa |
Equity: Sectoral-Pharma and Healthcare |
S&P BSE Healthcare TRI
NAV as on 15-01-2021
AUM as on 31-12-2020
Rtn ( Since Inception )
14.34%
Inception Date
Aug 05, 2005
Expense Ratio
2.52%
Fund Status
Open Ended Scheme
Min. Investment
5,000
Min. Topup
1,000
Min. SIP Amount
500
Risk Status
high
Investment Objective : An open-end fund which exclusively invests in the equities of the pharma & healthcare sector companies. This fund is one of the growth sector fund s aiming to invest in companies engaged in business of manufacturing and marketing of bulk drug, formulations and health care products and service.
Fund Performance
3 and 6 Months returns are absolute
Returns (%)
| 3 Mon | 6 Mon | 1 Yr | 3 Yrs | 5 Yrs | 10 Yrs | |
|---|---|---|---|---|---|---|
| Fund | 11.75 | 34.02 | 64.4 | 16.55 | 10.02 | 13.4 |
| S&P BSE Healthcare TRI | 9.05 | 34.22 | 46.65 | 10.48 | 4.91 | 12.39 |
| Equity: Sectoral-Pharma and Healthcare | 12.11 | 33.71 | 64.29 | 18.08 | 10.14 | 15.38 |
| Rank within Category | 5 | 5 | 6 | 3 | 2 | 3 |
| Number of Funds within Category | 9 | 9 | 9 | 4 | 4 | 3 |
Peer Comparison
| Return (%) | ||||||
|---|---|---|---|---|---|---|
| Scheme Name | AUM (crore) |
Expense Ratio |
1 Yr | 3 Yrs | 5 Yrs | 10 Yrs |
| UTI Healthcare Fund - Regular Plan - Growth Option | 649.26 | 2.52 | 64.4 | 16.55 | 10.02 | 13.4 |
| DSP Healthcare Fund - Regular Plan - Growth | 1,043.27 | 2.3 | 73.16 | 0.0 | 0.0 | 0.0 |
| ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option | 2,159.31 | 2.35 | 69.04 | 0.0 | 0.0 | 0.0 |
| Mirae Asset Healthcare Fund -Regular Growth | 1,209.93 | 2.25 | 68.85 | 0.0 | 0.0 | 0.0 |
| Nippon India Pharma Fund-Growth Plan-Growth Option | 4,383.33 | 2.05 | 66.18 | 21.5 | 13.13 | 16.51 |
| SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH | 1,575.33 | 2.26 | 65.77 | 15.15 | 7.97 | 16.24 |
| Tata India Pharma & Healthcare Fund-Regular Plan-Growth | 419.34 | 2.64 | 61.93 | 19.13 | 9.46 | 0.0 |
| IDBI Healthcare Fund - Regular Plan - Growth | 68.63 | 2.68 | 56.1 | 0.0 | 0.0 | 0.0 |
| Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | 459.12 | 2.71 | 53.16 | 0.0 | 0.0 | 0.0 |
Yearly Performance (%)
Historical Returns (%)
| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fund | -9.56 | 24.78 | 23.26 | 43.74 | 12.37 | -9.71 | 6.2 | -7.53 | 1.18 | 67.36 |
| S&P BSE Healthcare TRI | 0 | 0 | 0 | 0 | 0 | -12.43 | 1.1 | -5.38 | -2.8 | 44.55 |
| Equity: Sectoral-Pharma and Healthcare | -4.1 | 5.13 | -12.24 | 19.6 | 50.02 | 23.39 | 32.23 | -8.71 | 32.79 | - |
Returns Calculator
Growth of 10000 In SIP (Fund vs Benchmark)
Growth of 10000 In LUMPSUM (Fund vs Benchmark)
Rolling Returns
Rolling returns are the annualized returns of the scheme taken for a specified period (rolling returns period) on every day/week/month and taken till the last day of the duration. In this chart we are showing the annualized returns over the rolling returns period on every day from the start date and comparing it with the benchmark. Rolling returns is the best measure of a fund's performance. Trailing returns have a recency bias and point to point returns are specific to the period in consideration. Rolling returns, on the other hand, measures the fund's absolute and relative performance across all timescales, without bias.
Fund Multiplier
Riskometer
Asset Allocation
Top 10 Holdings
| Company | Instrument | Credit Rating | Holdings (%) |
|---|